Most Clicked StoriesMore >


FDA: SGLT2 inhibitors may cause ketoacidosis in diabetes patients

DiabetesPro SmartBrief | May 18, 2015

Type 2 diabetes patients who take SGLT2 inhibitors such as Farxiga, Invokana and Jardiance may experience ketoacidosis, the FDA warned. There were 20 reported cases of acidosis in diabetes patients treated with these drugs between March 2013 and June 6, 2014, all of whom were hospitalized or visited emergency departments. The FDA said it has continued to receive reports of adverse events since June 2014. Reuters (05/15)


PPAR agonist is safe for type 2 diabetes patients, study finds

DiabetesPro SmartBrief | May 19, 2015

Certified diabetes educators can help patients improve health measures

DiabetesPro SmartBrief | May 18, 2015

Lower A1C seen with medical nutrition therapy for obese pre-diabetes patients

DiabetesPro SmartBrief | May 21, 2015

Why you should consider drinking whole milk

DiabetesPro SmartBrief | May 20, 2015

Older diabetes patients may lower A1C with early insulin initiation

DiabetesPro SmartBrief | May 19, 2015

Study looks at benefits, risks of gastric bypass with diabetes

DiabetesPro SmartBrief | May 22, 2015

Diabetes, pre-diabetes may be identified through dental visits

DiabetesPro SmartBrief | May 18, 2015

Bariatric surgery improves health measures in diabetes, obese patients

DiabetesPro SmartBrief | May 20, 2015

A1C levels of diabetes patients improve during Ramadan

DiabetesPro SmartBrief | May 22, 2015


Find DiabetesPro SmartBrief Issues by Date:



ADA News More >


Performance improvement continuing education opportunity!

DiabetesPro SmartBrief | May 22, 2015

Peer-reviewed highlights from the 2014 Scientific Sessions-MD Conference Express

DiabetesPro SmartBrief | May 21, 2015

30th Annual Clinical Conference on Diabetes: Beyond the Numbers

DiabetesPro SmartBrief | May 20, 2015

Diabetes is Primary – CME Program

DiabetesPro SmartBrief | May 19, 2015

Are you a Professional Member?

DiabetesPro SmartBrief | May 19, 2015




Sign up for DiabetesPro SmartBrief



Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals. Learn more

Recent Poll view more polls


Poll: Do you think a glucose-sensing contact lens would be of benefit to your patients?

Chart.